Jacobio Strikes New Cancer Drug Deal with AstraZeneca Hong Kong-listed Chinese biotech firm Jacobio Pharma says it hopes to commercialize a new drug that its developing with AstraZeneca.…
AZN, Daiichis Enhertu Gets FDA Nod for First-Line Breast Cancer AstraZenecas Enhertu wins FDA nod as a first-line treatment for HER2-positive metastatic breast cancer.…
IRW-News: ACCESS Newswire: Eastman, AstraZeneca, Kraft Heinz und P&G mit OMP Supply Chain Awards ausgezeichnet IRW-PRESS: ACCESS Newswire: Eastman, AstraZeneca, Kraft Heinz und P&G mit OMP Supply Chain Awards ausgezeichnetMIAMI, FLORIDA / ACCESS Newswire /…
AstraZeneca’s Saphnelo approved in EU for self-administration in lupus By Investing.com AstraZeneca’s Saphnelo approved in EU for self-administration in lupus…
Astrazeneca (AZN) Rises As Market Takes a Dip: Key Facts Astrazeneca (AZN) closed the most recent trading day at $91.56, moving +1.93% from the previous trading session.…
Exclusive: US FDA launches fresh safety scrutiny of approved RSV therapies for infants U.S. health regulators informed senior executives at Merck, Sanofi and AstraZeneca last week that their approved protective RSV treatments for…
Leading bank tips AstraZeneca as 2026’s standout UK pharma, with GSK left trailing JPMorgan has put AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) at the top of its UK healthcare picks for 2026, arguing that the company…
AstraZeneca is top pharma tip for 2026, with GSK left trailing JPMorgan has put AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) at the top of its UK healthcare picks for 2026, arguing that the company…
ANALYSE-FLASH: JPMorgan hebt Novartis auf Overweight - Ziel 125 Franken NEW YORK (dpa-AFX Broker) - Die US-Bank JPMorgan hat das Kursziel für Novartis von 95 auf 125 Franken angehoben…
AstraZeneca or Merck: Which Oncology Giant Has the Edge? AZN and MRK boast major oncology strengths and expanding pipelines amid shifting market dynamics in this pharma matchup.…
Why Medicare price negotiations matter for Novo Nordisk, AstraZeneca, and other European pharma companies Pharma companies are facing pricing pressure from several directions, including from the U.S. Medicare negotiations…
Why AstraZeneca Stock Bumped Higher Today The company is wasting little time figuring out the particulars of a sweeping capital investment program.…
AstraZenecas $2B manufacturing investment in Maryland to create jobs AstraZeneca is investing $2 billion in manufacturing in Maryland that will support 2,600 jobs, state and company officials announced Friday.…
AstraZeneca to invest $2 billion expanding Maryland manufacturing sites By Investing.com AstraZeneca to invest $2 billion expanding Maryland manufacturing sites…
AstraZeneca to invest $2 billion as part of US manufacturing push AstraZeneca said on Friday it will invest $2 billion to expand its manufacturing footprint in Maryland as part of its…
Chutes & Ladders— Former FDA official to lead policy at Hims & Hers; ATA CEO to retire in December Welcome to this weeks Chutes & Ladders, our roundup of hirings, firings and retirings throughout the industry. Please submit the…
Why Astrazeneca (AZN) is a Top Growth Stock for the Long-Term The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why…
FTSE 100 hits record high as job market data weakens pound; AstraZeneca shines By Reuters FTSE 100 hits record high as job market data weakens pound; AstraZeneca shines…
Lisata (LSTA) Q3 2025 Earnings Call Transcript Image source: The Motley Fool.DATEThursday, Nov. 6, 2025 at 4:30 p.m. ETCALL PARTICIPANTSPresident and Chief Executive Officer — Dr. David…
AZN Q3 Earnings Top Estimates, Sales Rise As Most Key Drugs Outperform AstraZeneca posts strong Q3 results. Core earnings and revenues beat estimates as key drugs like Tagrisso, Imfinzi and Farxiga fuel…